13 drug companies have a plan to tackle one of the biggest looming health threats by 2020

The growing threat of bugs that are resistant to even last-resort medications will be the topic of a United Nations General Assembly meeting Wednesday.

Coinciding with that, 13 major drug companies have listed with four key commitments that they’re going to uphold by 2020 in an attempt to cut back on antimicrobial resistance — that is, resistance to medicines found in bacteria, viruses, fungi and parasites.

The goals are along the same lines as the ones laid out in January at the World Economic Forum in Davos, Switzerland.

The pharma companies include major players like Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, GlaxoSmithKline and Novartis.

As part of the 2020 plan, the companies said they would:

When it comes to antibiotic resistance, an estimated 23,000 Americans died in 2013 from bacterial infections that didn’t respond to antibiotics, and it’s getting to the point where gonorrhea may soon become untreatable, and bacteria have even begun developing resistance against antibiotics that are used as last resorts.

Here are all the companies that signed on to the 2020 commitment:

  • Allergan
  • AstraZeneca
  • Cipla
  • DSM Sinochem Pharmaceuticals
  • Roche
  • GSK
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • Shionogi
  • Wockhardt

NOW WATCH: The last harvest moon eclipse of the decade has come and gone — here’s what a harvest moon actually is

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.